'Reassuring' Safety Data on PPI Therapy - Medscape

PPIs were generally not associated with an increased risk for mortality due to major causes in a novel analysis accounting for potential protopathic bias.

In a novel analysis accounting for protopathic bias, proton pump inhibitor (PPI) therapy was not associated with increased risk for death due to digestive disease, cancer, cardiovascular disease (CVD… [+6287 chars]

full article...